Shopping Cart
- Remove All
- Your shopping cart is currently empty
Thalidomide-O-amido-PEG2-C2-NH2, which combines an E3 ligase ligand with a linker, serves as an immunomodulator for cancer treatment.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
100 mg | Inquiry | Backorder | |
500 mg | Inquiry | Backorder |
Description | Thalidomide-O-amido-PEG2-C2-NH2, which combines an E3 ligase ligand with a linker, serves as an immunomodulator for cancer treatment. |
In vitro | PROTACs consist of two distinct ligands joined by a linker: one ligand targets an E3 ubiquitin ligase, while the other targets the desired protein. These compounds leverage the intracellular ubiquitin-proteasome system to specifically degrade target proteins. |
Alias | Thalidomide-O-amido-PEG2-C2-NH2, E3LigaseLigand-LinkerConjugates24, Cereblon Ligand-Linker Conjugates 10 |
Molecular Weight | 462.459 |
Formula | C21H26N4O8 |
Cas No. | 1957235-74-3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.